Systemic ketamine toxicity following dermal application of a compounded pain cream.
The American Journal of Emergency Medicine February 1, 2025 Skyler Kessler, Bernard Weigel, Ross Ellison et al. 5 citations
Ketamine is an NMDA receptor antagonist commonly used as a dissociative anesthetic and analgesic. Though it is conventionally administered via the intravenous, intramuscular, or intranasal route, use as a compounded analgesic cream is becoming increasingly common. This is a case report of a 61-year-old man who was detained by the police for erratic driving. He was transported to the emergency...
DOI: 10.1016/j.ajem.2024.12.031 (opens in new tab)
Full text (opens in new tab)
Dermal application
Pain cream
Ketamine toxicity
Topical drug safety
+3